Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,951 public trials 2,018 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, Not Recruiting

Loncastuximab Tesirine in WM

NCT05190705

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Fred Hutch Seattle, Washington, United States
View Trial Details
Active, Not Recruiting

A Study of Acalabrutinib Plus Venetoclax Versus Venetoclax Plus Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT05057494

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Disease Attributes, +14 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site La Jolla, California, United States
  • Research Site Longmont, Colorado, United States
  • Research Site Jacksonville, Florida, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

Evolut™ EXPAND TAVR II Pivotal Trial

NCT05149755

Conditions
Constriction, Pathologic, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • University of Alabama at Birmingham (UAB) Hospital Birmingham, Alabama, United States
  • Abrazo Arizone Heart Hospital Phoenix, Arizona, United States
  • HonorHealth Scottsdale Shea Medical Center Scottsdale, Arizona, United States
  • Los Robles Hospital & Medical Center Thousand Oaks, California, United States
View all 94 locations
View Trial Details

Related conditions